Days At A Glance Speakers Posters Session Type Search
Type

    09:00 -  
    Registration
    11:00 - 12:30 
    Symposium 1: GnRH biology - from pulses to longevity
    Supported by Journal of Molecular Endocrinology
    1B
    Chairs: H Christian (Oxford) & R Perrett (Bristol)
    From novel insights into GnRH timing and central control of reproduction to new discoveries in hypothalamic inflammatory change and ageing
    S1.2
    Symposium 1: GnRH biology - from pulses to longevity
    Biological insights from genetically tagged gonadotropes
    S1.3
    Symposium 1: GnRH biology - from pulses to longevity
    GnRH and inflammatory signalling in the ageing hypothalamus
    Bronx, USA
    11:00 - 12:30 
    Symposium 2: The upside of glucocorticoids in metabolism
    Supported by Journal of Endocrinology
    1C
    Chairs: R Stimson (Edinburgh) & S Morgan (Birmingham)
    Amending our thinking of the way GCs work
    S2.1
    Symposium 2: The upside of glucocorticoids in metabolism
    Insulin sensitisation of adipose tissue by glucocorticoids
    S2.2
    Symposium 2: The upside of glucocorticoids in metabolism
    Maintaining the anti-inflammatory action of glucocorticoid without the metabolic side effects
    Toronto, Canada
    S2.3
    Symposium 2: The upside of glucocorticoids in metabolism
    Glucocorticoids and protection from pancreatic beta cell failure
    11:00 - 12:30 
    Symposium 3: Emerging Clinical importance of iodine
    Supported by Endocrine-Related Cancer and the British Thyroid Foundation
    3B
    Chairs: M Vanderpump (London) & J Waung (London)
    New clinical applications in iodine biology
    S3.1
    Symposium 3: Emerging Clinical importance of iodine
    Iodine nutrition and neurodevelopment
    S3.2
    Symposium 3: Emerging Clinical importance of iodine
    Regulation of NIS function in thyroid and breast cancer
    Los Angeles, USA
    S3.3
    Symposium 3: Emerging Clinical importance of iodine
    Use of radioiodine in the imaging and therapy of non-thyroidal tumours
    Munich, Germany
    11:00 - 12:30 
    Clinical Management Workshop 2: How do I do it?
    Supported by Endocrinology, Diabetes and Metabolism Case Reports CMW2.1 supported by Hypopara UK
    1A
    Chairs: J Ahlquist (Southend) & C Napier (Newcastle upon Tyne)
    CMW2.1
    Clinical Management Workshop 2: How do I do it?
    How do I localise parathyroid tumours?
    CMW2.2
    Clinical Management Workshop 2: How do I do it?
    How and when do I initiate treatment for central hypothyroidism?
    Milan, Italy
    CMW2.3
    Clinical Management Workshop 2: How do I do it?
    How do I manage adrenal replacement in pregnancy?
    CMW2.6
    Clinical Management Workshop 2: How do I do it?
    How do I investigate and manage hyponatraemia?
    CMW2.5
    Clinical Management Workshop 2: How do I do it?
    How and when do I treat the older male with a borderline testosterone?
    CMW2.4
    Clinical Management Workshop 2: How do I do it?
    How do I investigate and manage sweating?
    12:30 - 13:45 
    Lunch
    Hall 2A
    12:45 - 13:45 
    Internis Industry Sponsored Satellite Symposia
    Vitamin D – the Dark Truth
    1C
    Chair: A Grosso (London)
    Internis Industry Sponsored Satellite Symposia
    Clinical Update on Vitamin D
    Internis Industry Sponsored Satellite Symposia
    Shedding light on the Health Economics of Vitamin D
    Internis Industry Sponsored Satellite Symposia
    The Dark Truth of Prescribing Unlicensed Vitamin D
    12:45 - 13:45 
    HRA Pharma Industry Sponsored Satellite Symposia
    Cushing’s syndrome and adrenocortical carcinoma management: are we making progress?
    1B
    Chair: R Feelders (Rotterdam, Netherlands)
    HRA Pharma Industry Sponsored Satellite Symposia
    Welcome and introduction
    Rotterdam, Netherlands
    HRA Pharma Industry Sponsored Satellite Symposia
    Current challenges in the management of Cushing’s syndrome
    HRA Pharma Industry Sponsored Satellite Symposia
    Use of Steroidogenesis inhibitors for Cushing’s syndrome. Audit of 13 UK tertiary centres
    Sheffield, UK
    HRA Pharma Industry Sponsored Satellite Symposia
    Multimodal therapy in the management of advanced ACC
    HRA Pharma Industry Sponsored Satellite Symposia
    Questions and Answers
    13:45 - 15:15 
    Applied Physiology Workshop: A guide to the analysis of energy metabolism
    Supported by Journal of Endocrinology
    1B
    Chairs: G Lavery (Birmingham) & D Macfarlane (Dundee)
    How to assess and quantitate energy usage and interpret the data
    APW1.1
    Applied Physiology Workshop: A guide to the analysis of energy metabolism
    Assessing energy demand in living organisms
    Stockholm, Sweden
    APW1.2
    Applied Physiology Workshop: A guide to the analysis of energy metabolism
    Lipid metabolism: from mice to men?
    APW1.3
    Applied Physiology Workshop: A guide to the analysis of energy metabolism
    Tracking lipid energy partitioning in human liver
    13:45 - 15:15 
    Oral Communications 1: Young Endocrinologists' Prize Session
    1A
    Chairs: C McCabe (Birmingham) & S Mirczuk (London)
    OC1.1
    Oral Communications 1: Young Endocrinologists' Prize Session
    The Thr92Ala substitution in deiodonase-2 is associated with increased odds of a sub-optimal IQ score in children with low-normal thyroid function
    OC1.2
    Oral Communications 1: Young Endocrinologists' Prize Session
    Characterisation of adrenocortical progenitor cells: isolation of mesenchymal stem cell-like cell populations from human adrenal cortex
    OC1.3
    Oral Communications 1: Young Endocrinologists' Prize Session
    Angiogenic factors sFlt1 and PlGF are novel determinants of newborn thyroid (dys)function: the Generation R study
    OC1.4
    Oral Communications 1: Young Endocrinologists' Prize Session
    Single molecule analysis of GPCR transactivation reveals oligomeric complexes that regulate signal sensitivity
    London, UK
    OC1.5
    Oral Communications 1: Young Endocrinologists' Prize Session
    Kisspeptin - a novel physiological trigger for oocyte maturation in IVF treatment
    OC1.6
    Oral Communications 1: Young Endocrinologists' Prize Session
    A loss-of-function mutation in the prolactin receptor (PRLR) causes familial hyperprolactinaemia
    Birmingham, UK
    13:45 - 15:15 
    Symposium 4: Putting flesh on the bones
    3B
    Chairs: N Shaw (Birmingham) & S Howles (Oxford)
    Genetic disorders of bone and mineral metabolism
    S4.1
    Symposium 4: Putting flesh on the bones
    Assessment of abnormalities of skeletal development
    S4.2
    Symposium 4: Putting flesh on the bones
    Osteogenesis imperfecta - management beyond childhood
    S4.3
    Symposium 4: Putting flesh on the bones
    Management of hypophosphatemic rickets
    New Haven, USA
    15:15 - 15:45 
    Tea & Coffee
    Hall 2A
    15:45 - 17:15 
    Education Workshop 1: Teaching and learning in Endocrinology
    3B
    Chairs: A Crown (Brighton) & H Christian (Oxford)
    EW1.1
    Education Workshop 1: Teaching and learning in Endocrinology
    Endocrinologists as teachers: integrating teaching and practice in the real world
    EW1.2
    Education Workshop 1: Teaching and learning in Endocrinology
    Using technology to enhance your teaching in endocrinology
    EW1.3
    Education Workshop 1: Teaching and learning in Endocrinology
    Exams, and the future of assessment in medicine. A view from the MRCP(UK)
    EW1.4
    Education Workshop 1: Teaching and learning in Endocrinology
    Interprofessional learning through and for multidisciplinary working
    Education Workshop 1: Teaching and learning in Endocrinology
    Questions and discussion
    15:45 - 17:15 
    Clinical Management Workshop 1: Management of complex obesity
    Supported by Clinical Endocrinology
    1A
    Chairs: B McGowan (London) & K McCullough (London)
    CMW1.1
    Clinical Management Workshop 1: Management of complex obesity
    Have the new commissioning guidelines for bariatric surgery improved patient's pathways?
    CMW1.2
    Clinical Management Workshop 1: Management of complex obesity
    Medical management of severe obesity
    CMW1.3
    Clinical Management Workshop 1: Management of complex obesity
    Endocrine and metabolic complications post-bariatric surgery
    London, United Kingdom
    15:45 - 17:15 
    Oral Communications 2: Endocrine regulation of cell behaviour
    1B
    Chairs: G Lavery (Birmingham) & G WIllis (Cardiff)
    OC2.1
    Oral Communications 2: Endocrine regulation of cell behaviour
    A novel modulator of cell invasion and metastasis
    OC2.2
    Oral Communications 2: Endocrine regulation of cell behaviour
    Inhibition of human NET cell proliferation by a peptide identified through phage display screening
    OC2.3
    Oral Communications 2: Endocrine regulation of cell behaviour
    A20 confers protection against TRAIL-induced apoptosis in the pancreatic beta-cell
    OC2.4
    Oral Communications 2: Endocrine regulation of cell behaviour
    Influence of glucocorticoid receptor density on development and remodelling of the heart
    OC2.5
    Oral Communications 2: Endocrine regulation of cell behaviour
    Beta-cells require CFTR for glucose-induced insulin secretion
    OC2.6
    Oral Communications 2: Endocrine regulation of cell behaviour
    A potential role for food-derived microRNAs in human placental development
    15:45 - 17:15 
    Symposium 5: Endocrine consequences of major trauma
    1C
    Chairs: A Logan (Birmingham) & M Sherlock (Dublin, Ireland)
    Pathophysiological changes associated with injury
    S5.1
    Symposium 5: Endocrine consequences of major trauma
    Endocrine mechanisms of sarcopenia
    S5.2
    Symposium 5: Endocrine consequences of major trauma
    Pituitary sequelae of traumatic brain injury
    Dublin, Ireland
    S5.3
    Symposium 5: Endocrine consequences of major trauma
    Thyroid hormone economy in critical illness
    Amsterdam, The Netherlands
    17:25 - 18:25 
    SfE Young Endocrinologists' Prize Lectures
    1A
    Chairs: J Franklyn (Birmingham) & K Chapman (Edinburgh)
    YEP1.1
    SfE Young Endocrinologists' Prize Lectures
    Basic Prize Lecture: Sox2+ cells of the postnatal pituitary can differentiate into hormone producing cells in vivo and have tumour-inducing potential
    YEP1.2
    SfE Young Endocrinologists' Prize Lectures
    Clinical Prize Lecture: Clinical effects of kisspeptin on reproductive hormone secretion, LH pulsatility and oocyte maturation during IVF treatment
    18:25 - 19:15 
    Debate: This house believes Genome Wide Association Studies will have no impact upon clinical endocrinology
    1A
    Chair: B Walker (Edinburgh)
    Debate: This house believes Genome Wide Association Studies will have no impact upon clinical endocrinology
    For:
    Debate: This house believes Genome Wide Association Studies will have no impact upon clinical endocrinology
    Against:
    19:15 - 21:00 
    Welcome Reception
    Hall 2A
    20:15 - 22:00 
    Young Endocrinologists' Social Evening and Quiz
    3AB

    07:45 - 08:00 
    Breakfast
    07:45 -  
    Registration
    08:00 - 08:45 
    Meet the Expert 1
    Supported by Clinical Endocrinology
    3B
    Chair: J Newell-Price (Sheffield)
    MTE1
    Meet the Expert 1
    Medical management of Cushing's syndrome
    08:00 - 08:45 
    Meet the Expert 2
    Supported by Clinical Endocrinology
    1A
    Chair: N Gittoes (Birmingham)
    MTE2
    Meet the Expert 2
    Vitamin D replacement: how much, how often and for whom?
    08:00 - 08:45 
    Meet the Expert 3
    Supported by Clinical Endocrinology and the Klinefelter’s Syndrome Association UK
    1B
    Chair: H Jones (Barnsley)
    MTE3
    Meet the Expert 3
    Endocrine and non-endocrine management of Klinefelter's Syndrome
    Newcastle, UK
    08:00 - 08:45 
    Meet the Expert 4
    Supported by Clinical Endocrinology
    1C
    Chair: L Heisler (Cambridge)
    MTE4
    Meet the Expert 4
    Optogenetics illuminates neuroendocrinology
    09:00 - 10:30 
    Symposium 6: Thyroid cell biology comes to your clinic
    Supported by Journal of Molecular Endocrinology
    1C
    Chairs: C Spitzweg (Munich, Germany) & V Smith (Birmingham)
    Emerging models of clinical relevance to thyroid disease
    S6.1
    Symposium 6: Thyroid cell biology comes to your clinic
    Development of functional thyroid tissue from embryonic stem cells
    Brussels, Belgium
    S6.2
    Symposium 6: Thyroid cell biology comes to your clinic
    Factors involved in thyroid gland development and survival
    S6.3
    Symposium 6: Thyroid cell biology comes to your clinic
    PBF signalling in thyroid tumourigenesis
    Birmingham, UK
    09:00 - 10:30 
    Clinical Management Workshop 2: How do I do it?
    Supported by Endocrinology, Diabetes and Metabolism Case Reports CMW2.1 supported by Hypopara UK
    1A
    Chairs: J Ahlquist (Southend) & C Napier (Newcastle upon Tyne)
    CMW2.1
    Clinical Management Workshop 2: How do I do it?
    How do I localise parathyroid tumours?
    CMW2.2
    Clinical Management Workshop 2: How do I do it?
    How and when do I initiate treatment for central hypothyroidism?
    Milan, Italy
    CMW2.3
    Clinical Management Workshop 2: How do I do it?
    How do I manage adrenal replacement in pregnancy?
    CMW2.4
    Clinical Management Workshop 2: How do I do it?
    How do I investigate and manage sweating?
    CMW2.5
    Clinical Management Workshop 2: How do I do it?
    How and when do I treat the older male with a borderline testosterone?
    CMW2.6
    Clinical Management Workshop 2: How do I do it?
    How do I investigate and manage hyponatraemia?
    09:00 - 10:30 
    Oral Communications 3: Steroids
    3B
    Chairs: C Cummins (Toronto, Canada) & D Nanus (Birmingham)
    OC3.1
    Oral Communications 3: Steroids
    Lack of 11β-hydroxysteroid dehydrogenase type 1 ameliorates the adverse features of Cushing’s syndrome
    OC3.2
    Oral Communications 3: Steroids
    5α-Reductase is a regulator of glucocorticoid action and metabolic phenotype in human liver
    OC3.3
    Oral Communications 3: Steroids
    The 21-hydroxylase pseudogene may have a role in induction of tolerance to steroidogenic machinery
    OC3.4
    Oral Communications 3: Steroids
    Pre-receptor glucocorticoid metabolism across human ageing: the impact of gender and menopausal status
    OC3.5
    Oral Communications 3: Steroids
    Linking GWAS to gene function - CYP17A1 in hypertension
    OC3.6
    Oral Communications 3: Steroids
    Targeting of lysyl oxidase by steroids to reduce peritoneal fibrosis and scarring
    09:00 - 10:30 
    Symposium 7: Natriuretic peptides: so much more than salt and water
    1B
    Chairs: C McArdle (Bristol) & S Mirczuk (London)
    Novel functions for natriuretic peptides
    S7.1
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Guanylyl cyclases in cardiomyopathy
    Wuerzburg, Germany
    S7.2
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Natriuretic peptides in pituitary development and function
    S7.3
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Natriuretic peptides in cardiovascular disease
    10:30 - 11:00 
    Tea & Coffee
    Hall 2A
    11:00 - 11:30 
    Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
    1A
    Chair: A Grossman (Oxford)
    PL1
    Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
    Nuclear receptors, metabolism and the hunger games
    La Jolla, USA
    11:30 - 12:00 
    Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
    1A
    Chair: A Grossman (Oxford)
    PL2
    Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
    Coactivators: Master Genes for Physiology and Pathology
    Pittsburg, USA
    12:00 - 14:00 
    Lunch & poster viewing
    Odd-numbered posters attended 12:00 - 13:00; Even-numbered posters attended 13:00 - 14:00
    Hall 2A
    12:45 - 13:45 
    Ipsen Industry Sponsored Satellite Symposia
    Optimising outcomes for patients with acromegaly and NETs
    3AB
    Chair: A Grossman (Oxford)
    Ipsen Industry Sponsored Satellite Symposia
    High-dose lanreotide Autogel for treatment-naive patients with acromegaly: the results of the PRIMARYS trial
    Ipsen Industry Sponsored Satellite Symposia
    SAGIT – A disease staging tool to personalise patient management for acromegaly
    Hamburg, Germany
    Ipsen Industry Sponsored Satellite Symposia
    New data confirming the beneficial role of lanreotide Autogel in the management of patients with a NET
    Cardiff, United Kingdom
    14:00 - 15:30 
    Oral Communications 4: Thyroid and Bone
    1C
    Chairs: K Boelaert (Birmingham) & F Hannan (Liverpool)
    OC4.1
    Oral Communications 4: Thyroid and Bone
    Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 exert dominant-negative effects
    OC4.2
    Oral Communications 4: Thyroid and Bone
    PHOSPHO1: roles beyond skeletal mineralisation
    OC4.3
    Oral Communications 4: Thyroid and Bone
    TRα mutation causes a severe and thyroxine-resistant skeletal dysplasia
    OC4.4
    Oral Communications 4: Thyroid and Bone
    Thyroid hormones stimulate osteoclastogenesis via TRα-dependent actions in osteoblasts
    OC4.5
    Oral Communications 4: Thyroid and Bone
    A mutation in the 5’UTR of GNA11 causes familial hypocalciuric hypercalcemia type 2 (FHH2) due to reduced translational efficiency
    OC4.6
    Oral Communications 4: Thyroid and Bone
    An ENU-induced Tyr265Stop mutation in Polg2 is associated with renal calcification in RCALC2 mice
    Birmingham, UK
    14:00 - 15:30 
    Young Endocrinologists' Symposium: Establishing successful collaborations
    1B
    Chairs: A Lansdown (Cardiff) & G Begum (Manchester)
    Making the most of interdisciplinary collaborations and peer-to-peer networking
    YE1.1
    Young Endocrinologists' Symposium: Establishing successful collaborations
    What makes a successful collaboration between a basic scientist and a clinician?
    YE1.2
    Young Endocrinologists' Symposium: Establishing successful collaborations
    How do I talk to a bioinformatician/mathematician/engineer?
    YE1.3
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Industrial collaborations - where to start?
    YE1.4
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Biobanking – what is it, and how could they be beneficial to me?
    YE1.5
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Peer-to-peer collaborations: Importance of YE groups
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Panel discussion
    14:00 - 15:30 
    Symposium 8: Chronic disease and growth
    3B
    Chairs: F Ahmed (Glasgow) & L Dunford (Leicester)
    Chronic inflammation and growth hormone signalling
    S8.1
    Symposium 8: Chronic disease and growth
    Understanding growth hormone action through the growth plate
    S8.2
    Symposium 8: Chronic disease and growth
    Targeting SOCS Proteins to Combat Inflammation
    S8.3
    Symposium 8: Chronic disease and growth
    Managing abnormalities of growth in chronic disease
    Paris, France
    14:00 - 15:30 
    Symposium 9: MEN1- from molecular pathology to therapies
    Supported by Endocrine-Related Cancer and the Association of Multiple Endocrine Neoplasia Disorders
    1A
    Chairs: J Newell-Price (Sheffield) & G Walls (Oxford)
    Current understanding and future perspectives in MEN1
    S9.1
    Symposium 9: MEN1- from molecular pathology to therapies
    Current understanding and future perspectives in MEN1
    Bethesda, USA
    S9.2
    Symposium 9: MEN1- from molecular pathology to therapies
    Genetics, pathophysiology and translational models of MEN1
    Oxford, United Kingdom
    S9.3
    Symposium 9: MEN1- from molecular pathology to therapies
    Practical management of patients with MEN1
    Uppsala, Sweden
    15:30 - 16:00 
    Tea & Coffee
    Hall 2A
    16:00 - 16:45 
    Meet the Expert 3 (repeat)
    Supported by Clinical Endocrinology and the Klinefelter’s Syndrome Association UK
    3B
    Chair: H Jones (Barnsley)
    MTE3
    Meet the Expert 3 (repeat)
    Endocrine and non-endocrine management of Klinefelter's Syndrome (repeat)
    Newcastle, UK
    16:00 - 17:30 
    Oral Communications 5: Pituitary
    1B
    Chairs: J Davies (Manchester) & R Watkins (Birmingham)
    OC5.1
    Oral Communications 5: Pituitary
    Increased frequency and earlier onset of pituitary tumours in mice deleted for a multiple endocrine neoplasia type 1 (MEN1) allele and null for prolyl hydroxylase domain protein 1 (PHD1) (Men1+/-/Phd1-/-)
    OC5.2
    Oral Communications 5: Pituitary
    Implications of the upregulation of lysine specific demethylase (LSD) 1 in the pathogenesis of pituitary adenomas
    OC5.3
    Oral Communications 5: Pituitary
    The Wnt/β-catenin effector Tcf3/TCF7L1 is required for normal hypothalamic-pituitary development and mutation in this gene is associated with congenital hypopituitarism
    OC5.4
    Oral Communications 5: Pituitary
    GnRH pulse frequency-dependent regulation of ICER, a modulator of FSHβ transcription, is attenuated by MEKI/II blockade
    OC5.5
    Oral Communications 5: Pituitary
    Spatio-temporal analysis of prolactin gene transcription dynamics reveals short range co-ordination of lactotroph transcription activity in pituitary tissue
    OC5.6
    Oral Communications 5: Pituitary
    A GH antagonist fusion with GH binding protein is biologically active, shows delayed clearance and inhibits growth in a rabbit model
    16:00 - 17:30 
    Symposium 10: Fat and bone
    Supported by Endocrine Connections and the Klinefelter’s Syndrome Association UK
    1A
    Chairs: P Dimitri (Sheffield) & R Crowley (Birmingham)
    Body composition and bone
    S10.1
    Symposium 10: Fat and bone
    Fat and its influence on bone
    S10.2
    Symposium 10: Fat and bone
    Obesity and fractures - what is the inter-relationship?
    S10.3
    Symposium 10: Fat and bone
    Energy Deficiency, Amenorrhea and the Skeleton:  Challenges and Therapies
    16:45 - 17:30 
    Meet the Expert 5
    Supported by Clinical Endocrinology
    3B
    Chair: P Trainer (Manchester)
    MTE5
    Meet the Expert 5
    Pituitary replacement therapy
    17:40 - 18:10 
    Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
    Supported by Clinical Endocrinology Trust
    1A
    Chair: J Connell (Dundee)
    PL3
    Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
    Adrenocortical tumours - from bench to bedside and back
    Würzburg, Germany
    19:30 -  
    Conference dinner and Awards Ceremony
    07:45 - 08:00 
    Breakfast
    08:00 - 08:45 
    Meet the Expert 5 (repeat)
    Supported by Clinical Endocrinology
    1A
    Chair: P Trainer (Manchester)
    MTE5
    Meet the Expert 5 (repeat)
    Pituitary replacement therapy (repeat)
    08:00 - 08:45 
    Meet the Expert 6
    Supported by Clinical Endocrinology
    3B
    Chair: C Brain (London)
    MTE6
    Meet the Expert 6
    Delayed puberty
    08:00 - 08:45 
    Meet the Expert 7
    Supported by Clinical Endocrinology and the Thyroid Eye Disease Charitable Trust
    1B
    Chair: J Gilbert (London)
    MTE7
    Meet the Expert 7
    Who should the endocrinologist ask the ophtalmologist to review?
    London, UK
    08:00 - 08:45 
    Society for Endocrinology Journal Awards
    1C
    Chair: D Ray (Manchester)
    JA 1
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Journal of Endocrinology: Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy
    Rochester, USA on behalf of the author group
    JA 2
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Journal of Molecular Endocrinology:Thyroid-specific inactivation of KIF3A alters TSH signaling pathway and leads to hypothyroidism
    Louvain-la-Neuve, Belgium on behalf of the author group
    JA 3
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Endocrine-Related Cancer: Highly prevalent TERT promoter mutations in aggressive thyroid cancers
    Baltimore, USA on behalf of the author group
    JA 4
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Clinical Endocrinology: What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS)
    JA 5
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Endocrine Connections: PKA regulatory subunit R2B is required for murine and human adipocyte differentiation
    Milan, Italy on behalf of the author group
    08:45 - 09:25 
    Society for Endocrinology AGM
    1A
    09:30 - 11:00 
    Education Workshop 2: Practical publishing advice
    3B
    Chair: D Ray (Manchester)
    EW2.1
    Education Workshop 2: Practical publishing advice
    Introduction
    EW2.2
    Education Workshop 2: Practical publishing advice
    Publishing ethics: Fabrication, Falsification and Plagiarism
    EW2.3
    Education Workshop 2: Practical publishing advice
    The peer review process
    Stockholm, Sweden
    EW2.4
    Education Workshop 2: Practical publishing advice
    Writing an attention grabbing abstract
    Essen, Germany
    EW2.5
    Education Workshop 2: Practical publishing advice
    Responding to reviewer comments
    EW2.6
    Education Workshop 2: Practical publishing advice
    The art of scientific writing
    London, UK
    EW2.7
    Education Workshop 2: Practical publishing advice
    Open Access
    Education Workshop 2: Practical publishing advice
    Questions and discussion
    09:30 - 11:00 
    Nurse Session 1 - Cushing's Syndrome
    1B
    Chairs: N Kieffer (Leicester) & J Andrew (Leeds)
    N1.1
    Nurse Session 1 - Cushing's Syndrome
    Investigating and Diagnosing Cushing’s Syndrome -not as straightforward as it seems?
    N1.2
    Nurse Session 1 - Cushing's Syndrome
    The role of the Endocrine Nurse in the Management of patients with Cushing’s syndrome
    Rotterdam, The Netherlands
    N1.3
    Nurse Session 1 - Cushing's Syndrome
    Why do ‘cured’ Cushing’s patients need long-term follow up?
    Barcelona, Spain
    N1.4
    Nurse Session 1 - Cushing's Syndrome
    Cushing’s patient experience
    09:30 - 11:00 
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    1C
    Chairs: S O'Rahilly (Cambridge) & S Virtue (Cambridge)
    Emerging biology of brown adipose tissue
    S11.1
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    Mechanisms of brown adipocyte determination
    Philadelphia, USA
    S11.2
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    The metabolic capacities of brown adipose tissue
    Stockholm, Sweden
    S11.3
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    How brown is human brown adipose tissue?
    Gothenburg, Sweden
    09:30 - 11:00 
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Supported by Clinical Endocrinology
    1A
    Chairs: H Gleeson (Leicester) & R El-Khairi (London)
    CMW3.1
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Adolescent health care in the UK in 2014
    CMW3.2
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Adrenal replacement in adolescents and young adults
    London, UK
    CMW3.3
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Optimising bone health in adolescents and young adults
    Birmingham, UK
    11:00 - 11:30 
    Tea & Coffee
    Exhibtion Hall
    11:30 - 12:00 
    Plenary Lecture 4: Society for Endocrinology European Medal Lecture
    1A
    Chair: G Williams (London)
    PL4
    Plenary Lecture 4: Society for Endocrinology European Medal Lecture
    Mechanisms of thyroid hormone resistance
    Rotterdam, Netherlands
    12:00 - 12:30 
    Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
    1A
    Chair: D Ray (Manchester)
    PL5
    Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
    Transcriptional Coordination of Circadian and Metabolic Physiology
    Philadelphia, USA
    12:30 - 13:45 
    Lunch & poster viewing
    Shortlisted posters attended
    Hall 2A
    12:45 - 13:45 
    Viropharma Industry Sponsored Satellite Symposia
    New insights in the management of Adrenal Insufficiency in the UK
    3AB
    Chair: S Pearce (Newcastle-Upon-Tyne)
    Viropharma Industry Sponsored Satellite Symposia
    Introduction: The unmet medical need in adrenal insufficiency and the importance of circadian rhythm
    Newcastle, UK
    Viropharma Industry Sponsored Satellite Symposia
    Adrenal Insufficiency today: the Salford project
    Viropharma Industry Sponsored Satellite Symposia
    Adrenal Insufficiency today: a report from the EU-AIR registry
    Leeds, UK
    Viropharma Industry Sponsored Satellite Symposia
    Patient cases and physician experience
    Naples, Italy
    Viropharma Industry Sponsored Satellite Symposia
    Closing remarks
    Newcastle, UK
    13:45 - 14:30 
    Meet the Expert 8
    1C
    Chair: C McCabe (Birmingham)
    MTE8
    Meet the Expert 8
    Growing organs in the lab
    13:45 - 15:15 
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    1B
    Chairs: L Shephard (Birmingham) & V Fazal-Sanderson (Oxford)
    N2.1
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    Background on the journey of endocrine nursing research
    N2.2
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    How to audit and evaluate your own practice
    N2.3
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    The role of the endocrine nurse in clinical trials
    N2.4
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    Independent nursing research
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    Questions and discussion
    13:45 - 15:15 
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    Supported by Endocrine Connections
    1A
    Chairs: R McCrimmon (Dundee) & B Challis (Cambridge)
    How the brain orchestrates glucose metabolism
    S12.1
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    How the brain senses blood glucose
    S12.2
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    Vagal control of energy metabolism
    S12.3
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    Does glucagon need the brain for its effects on blood glucose?
    13:45 - 15:15 
    Oral Communications 6: Clinical
    3B
    Chairs: R Semple (Cambridge) & A Puttanna (Walsall)
    OC6.1
    Oral Communications 6: Clinical
    Adverse outcome in glucocorticoid-induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
    OC6.2
    Oral Communications 6: Clinical
    Localising parathyroid adenomas. Which imaging modality is best? Pre-operative localisation studies in patients with primary hyperparathyroidism: a large audit in a London tertiary centre
    OC6.3
    Oral Communications 6: Clinical
    Sirolimus therapy for a patient with segmental overgrowth due to a mosaic activating mutation in phosphatidylinositol-3-kinase (PI3K)
    OC6.4
    Oral Communications 6: Clinical
    Reduced cognitive performance and altered white matter microstructure in young insulin-resistant women with polycystic ovary syndrome
    OC6.5
    Oral Communications 6: Clinical
    Effectiveness of metyrapone in 195 patients with Cushing’s syndrome
    OC6.6
    Oral Communications 6: Clinical
    11C-Methionine PET-CT co-registered with volume MRI: a novel adjunctive imaging modality to aid diagnosis and management in patients with pituitary adenomas
    14:30 - 15:15 
    Meet the Expert 9
    1C
    Chairs: H Turner (Oxford) & P Hadoke (Edinburgh)
    MTE9
    Meet the Expert 9
    Novel techniques to assess angiogenesis
    Paris, France
    15:15 - 15:45 
    Tea & Coffee
    Hall 2A
    15:45 - 16:15 
    Oral Communication and Poster Prize Ceremony
    1A
    Chairs: A Grossman (Oxford) & C McCabe (Birmingham)
    16:15 - 16:45 
    Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
    Supported by Clinical Endocrinology Trust
    1A
    Chair: G Williams (London)
    PL6
    Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
    Disorders of thyroid hormone action: insights from human genetics
    Cambridge, UK
    16:45 - 17:15 
    Plenary Lecture 7: Society for Endocrinology Medal Lecture
    1A
    Chair: D Ray (Manchester)
    PL7
    Plenary Lecture 7: Society for Endocrinology Medal Lecture
    The clock in the pituitary gland: timing annual cycles
    07:45 - 08:00 
    Breakfast
    08:00 - 08:45 
    Meet the Expert 1 (repeat)
    Supported by Clinical Endocrinology
    1B
    Chair: J Newell-Price (Sheffield)
    MTE1
    Meet the Expert 1 (repeat)
    Medical management of Cushing's syndrome (repeat)
    08:00 - 08:45 
    Meet the Expert 2 (repeat)
    Supported by Clinical Endocrinology
    1C
    Chair: N Gittoes (Birmingham)
    MTE2
    Meet the Expert 2 (repeat)
    Vitamin D replacement: how much, how often and for whom? (repeat)
    08:45 - 09:15 
    Plenary Lecture 8: Clinical Endocrinology Trust Lecture
    Supported by the Clinical Endocrinology Trust
    1A
    Chair: JS Bevan (Aberdeen)
    PL8
    Plenary Lecture 8: Clinical Endocrinology Trust Lecture
    Understanding glucocorticoid action, and the role of the glucocorticoid receptor
    09:15 - 09:45 
    Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
    1A
    Chair: C McCabe (Birmingham)
    PL9
    Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
    Male Fertility Regulation; achievements and frustrations
    Clayton, Australia
    09:45 - 10:15 
    Society for Endocrinology Emergency Endocrine Guidance
    1A
    Chair: J Franklyn (Birmingham)
    SFE1.1
    Society for Endocrinology Emergency Endocrine Guidance
    Acute Hypercalcaemia and Acute Hypocalcaemia
    UK
    SFE1.2
    Society for Endocrinology Emergency Endocrine Guidance
    Pituitary Apoplexy
    10:15 - 10:45 
    Tea & Coffee
    3AB
    10:45 - 11:30 
    Meet the Expert 6 (repeat)
    1B
    Chair: C Brain (London)
    MTE6
    Meet the Expert 6 (repeat)
    Delayed puberty (repeat)
    10:45 - 12:15 
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Supported by Endocrinology, Diabetes & Metabolism Case Reports and the Turner Syndrome Support Society
    1A
    Chairs: A Bates (Stourbridge) & J Thomas (Taunton)
    CMW4.1
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Cardiovascular risk in Turner's syndrome
    CMW4.2
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Valvular disease in prolactinomas- weighing up the evidence
    London, UK
    CMW4.3
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Cardiovascular risk in childhood cancer survivors
    10:45 - 12:45 
    Senior Endocrinologists' Session
    1C
    Chairs: B Cooke (Harpenden) & P Belchetz (Wetherby)
    SE1.4
    Senior Endocrinologists' Session
    The Foundling Hospital
    SE1.2
    Senior Endocrinologists' Session
    1776 Revolution in Liverpool. Matthew Dobson discovers Hyperglycaemia!
    SE1.3
    Senior Endocrinologists' Session
    Macroprolacin - To seek or ignore : a Trans-Atlantic Divide
    Dublin, Ireland
    SE1.1
    Senior Endocrinologists' Session
    How important is luck for major discoveries?
    SE1.5
    Senior Endocrinologists' Session
    Steroid Merchants of Edinburgh
    11:30 - 12:15 
    Meet the Expert 7 (repeat)
    Supported by Clinical Endocrinology and the Thyroid Eye Disease Charitable Trust
    1B
    Chair: J Gilbert (London)
    MTE7
    Meet the Expert 7 (repeat)
    Whom should the endocrinologist ask the ophtalmologist to review? (repeat)
    London, UK

    07:45 - 08:00 
    Breakfast
    07:45 -  
    Registration
    08:00 - 08:45 
    Meet the Expert 1
    Supported by Clinical Endocrinology
    3B
    Chair: J Newell-Price (Sheffield)
    MTE1
    Meet the Expert 1
    Medical management of Cushing's syndrome
    08:00 - 08:45 
    Meet the Expert 2
    Supported by Clinical Endocrinology
    1A
    Chair: N Gittoes (Birmingham)
    MTE2
    Meet the Expert 2
    Vitamin D replacement: how much, how often and for whom?
    08:00 - 08:45 
    Meet the Expert 3
    Supported by Clinical Endocrinology and the Klinefelter’s Syndrome Association UK
    1B
    Chair: H Jones (Barnsley)
    MTE3
    Meet the Expert 3
    Endocrine and non-endocrine management of Klinefelter's Syndrome
    Newcastle, UK
    08:00 - 08:45 
    Meet the Expert 4
    Supported by Clinical Endocrinology
    1C
    Chair: L Heisler (Cambridge)
    MTE4
    Meet the Expert 4
    Optogenetics illuminates neuroendocrinology
    09:00 - 10:30 
    Symposium 6: Thyroid cell biology comes to your clinic
    Supported by Journal of Molecular Endocrinology
    1C
    Chairs: C Spitzweg (Munich, Germany) & V Smith (Birmingham)
    Emerging models of clinical relevance to thyroid disease
    S6.1
    Symposium 6: Thyroid cell biology comes to your clinic
    Development of functional thyroid tissue from embryonic stem cells
    Brussels, Belgium
    S6.2
    Symposium 6: Thyroid cell biology comes to your clinic
    Factors involved in thyroid gland development and survival
    S6.3
    Symposium 6: Thyroid cell biology comes to your clinic
    PBF signalling in thyroid tumourigenesis
    Birmingham, UK
    09:00 - 10:30 
    Clinical Management Workshop 2: How do I do it?
    Supported by Endocrinology, Diabetes and Metabolism Case Reports CMW2.1 supported by Hypopara UK
    1A
    Chairs: J Ahlquist (Southend) & C Napier (Newcastle upon Tyne)
    CMW2.1
    Clinical Management Workshop 2: How do I do it?
    How do I localise parathyroid tumours?
    CMW2.2
    Clinical Management Workshop 2: How do I do it?
    How and when do I initiate treatment for central hypothyroidism?
    Milan, Italy
    CMW2.3
    Clinical Management Workshop 2: How do I do it?
    How do I manage adrenal replacement in pregnancy?
    CMW2.4
    Clinical Management Workshop 2: How do I do it?
    How do I investigate and manage sweating?
    CMW2.5
    Clinical Management Workshop 2: How do I do it?
    How and when do I treat the older male with a borderline testosterone?
    CMW2.6
    Clinical Management Workshop 2: How do I do it?
    How do I investigate and manage hyponatraemia?
    09:00 - 10:30 
    Oral Communications 3: Steroids
    3B
    Chairs: C Cummins (Toronto, Canada) & D Nanus (Birmingham)
    OC3.1
    Oral Communications 3: Steroids
    Lack of 11β-hydroxysteroid dehydrogenase type 1 ameliorates the adverse features of Cushing’s syndrome
    OC3.2
    Oral Communications 3: Steroids
    5α-Reductase is a regulator of glucocorticoid action and metabolic phenotype in human liver
    OC3.3
    Oral Communications 3: Steroids
    The 21-hydroxylase pseudogene may have a role in induction of tolerance to steroidogenic machinery
    OC3.4
    Oral Communications 3: Steroids
    Pre-receptor glucocorticoid metabolism across human ageing: the impact of gender and menopausal status
    OC3.5
    Oral Communications 3: Steroids
    Linking GWAS to gene function - CYP17A1 in hypertension
    OC3.6
    Oral Communications 3: Steroids
    Targeting of lysyl oxidase by steroids to reduce peritoneal fibrosis and scarring
    09:00 - 10:30 
    Symposium 7: Natriuretic peptides: so much more than salt and water
    1B
    Chairs: C McArdle (Bristol) & S Mirczuk (London)
    Novel functions for natriuretic peptides
    S7.1
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Guanylyl cyclases in cardiomyopathy
    Wuerzburg, Germany
    S7.2
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Natriuretic peptides in pituitary development and function
    S7.3
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Natriuretic peptides in cardiovascular disease
    10:30 - 11:00 
    Tea & Coffee
    Hall 2A
    11:00 - 11:30 
    Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
    1A
    Chair: A Grossman (Oxford)
    PL1
    Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
    Nuclear receptors, metabolism and the hunger games
    La Jolla, USA
    11:30 - 12:00 
    Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
    1A
    Chair: A Grossman (Oxford)
    PL2
    Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
    Coactivators: Master Genes for Physiology and Pathology
    Pittsburg, USA
    12:00 - 14:00 
    Lunch & poster viewing
    Odd-numbered posters attended 12:00 - 13:00; Even-numbered posters attended 13:00 - 14:00
    Hall 2A
    12:45 - 13:45 
    Ipsen Industry Sponsored Satellite Symposia
    Optimising outcomes for patients with acromegaly and NETs
    3AB
    Chair: A Grossman (Oxford)
    Ipsen Industry Sponsored Satellite Symposia
    High-dose lanreotide Autogel for treatment-naive patients with acromegaly: the results of the PRIMARYS trial
    Ipsen Industry Sponsored Satellite Symposia
    SAGIT – A disease staging tool to personalise patient management for acromegaly
    Hamburg, Germany
    Ipsen Industry Sponsored Satellite Symposia
    New data confirming the beneficial role of lanreotide Autogel in the management of patients with a NET
    Cardiff, United Kingdom
    14:00 - 15:30 
    Oral Communications 4: Thyroid and Bone
    1C
    Chairs: K Boelaert (Birmingham) & F Hannan (Liverpool)
    OC4.1
    Oral Communications 4: Thyroid and Bone
    Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 exert dominant-negative effects
    OC4.2
    Oral Communications 4: Thyroid and Bone
    PHOSPHO1: roles beyond skeletal mineralisation
    OC4.3
    Oral Communications 4: Thyroid and Bone
    TRα mutation causes a severe and thyroxine-resistant skeletal dysplasia
    OC4.4
    Oral Communications 4: Thyroid and Bone
    Thyroid hormones stimulate osteoclastogenesis via TRα-dependent actions in osteoblasts
    OC4.5
    Oral Communications 4: Thyroid and Bone
    A mutation in the 5’UTR of GNA11 causes familial hypocalciuric hypercalcemia type 2 (FHH2) due to reduced translational efficiency
    OC4.6
    Oral Communications 4: Thyroid and Bone
    An ENU-induced Tyr265Stop mutation in Polg2 is associated with renal calcification in RCALC2 mice
    Birmingham, UK
    14:00 - 15:30 
    Young Endocrinologists' Symposium: Establishing successful collaborations
    1B
    Chairs: A Lansdown (Cardiff) & G Begum (Manchester)
    Making the most of interdisciplinary collaborations and peer-to-peer networking
    YE1.1
    Young Endocrinologists' Symposium: Establishing successful collaborations
    What makes a successful collaboration between a basic scientist and a clinician?
    YE1.2
    Young Endocrinologists' Symposium: Establishing successful collaborations
    How do I talk to a bioinformatician/mathematician/engineer?
    YE1.3
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Industrial collaborations - where to start?
    YE1.4
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Biobanking – what is it, and how could they be beneficial to me?
    YE1.5
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Peer-to-peer collaborations: Importance of YE groups
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Panel discussion
    14:00 - 15:30 
    Symposium 8: Chronic disease and growth
    3B
    Chairs: F Ahmed (Glasgow) & L Dunford (Leicester)
    Chronic inflammation and growth hormone signalling
    S8.1
    Symposium 8: Chronic disease and growth
    Understanding growth hormone action through the growth plate
    S8.2
    Symposium 8: Chronic disease and growth
    Targeting SOCS Proteins to Combat Inflammation
    S8.3
    Symposium 8: Chronic disease and growth
    Managing abnormalities of growth in chronic disease
    Paris, France
    14:00 - 15:30 
    Symposium 9: MEN1- from molecular pathology to therapies
    Supported by Endocrine-Related Cancer and the Association of Multiple Endocrine Neoplasia Disorders
    1A
    Chairs: J Newell-Price (Sheffield) & G Walls (Oxford)
    Current understanding and future perspectives in MEN1
    S9.1
    Symposium 9: MEN1- from molecular pathology to therapies
    Current understanding and future perspectives in MEN1
    Bethesda, USA
    S9.2
    Symposium 9: MEN1- from molecular pathology to therapies
    Genetics, pathophysiology and translational models of MEN1
    Oxford, United Kingdom
    S9.3
    Symposium 9: MEN1- from molecular pathology to therapies
    Practical management of patients with MEN1
    Uppsala, Sweden
    15:30 - 16:00 
    Tea & Coffee
    Hall 2A
    16:00 - 16:45 
    Meet the Expert 3 (repeat)
    Supported by Clinical Endocrinology and the Klinefelter’s Syndrome Association UK
    3B
    Chair: H Jones (Barnsley)
    MTE3
    Meet the Expert 3 (repeat)
    Endocrine and non-endocrine management of Klinefelter's Syndrome (repeat)
    Newcastle, UK
    16:00 - 17:30 
    Oral Communications 5: Pituitary
    1B
    Chairs: J Davies (Manchester) & R Watkins (Birmingham)
    OC5.1
    Oral Communications 5: Pituitary
    Increased frequency and earlier onset of pituitary tumours in mice deleted for a multiple endocrine neoplasia type 1 (MEN1) allele and null for prolyl hydroxylase domain protein 1 (PHD1) (Men1+/-/Phd1-/-)
    OC5.2
    Oral Communications 5: Pituitary
    Implications of the upregulation of lysine specific demethylase (LSD) 1 in the pathogenesis of pituitary adenomas
    OC5.3
    Oral Communications 5: Pituitary
    The Wnt/β-catenin effector Tcf3/TCF7L1 is required for normal hypothalamic-pituitary development and mutation in this gene is associated with congenital hypopituitarism
    OC5.4
    Oral Communications 5: Pituitary
    GnRH pulse frequency-dependent regulation of ICER, a modulator of FSHβ transcription, is attenuated by MEKI/II blockade
    OC5.5
    Oral Communications 5: Pituitary
    Spatio-temporal analysis of prolactin gene transcription dynamics reveals short range co-ordination of lactotroph transcription activity in pituitary tissue
    OC5.6
    Oral Communications 5: Pituitary
    A GH antagonist fusion with GH binding protein is biologically active, shows delayed clearance and inhibits growth in a rabbit model
    16:00 - 17:30 
    Symposium 10: Fat and bone
    Supported by Endocrine Connections and the Klinefelter’s Syndrome Association UK
    1A
    Chairs: P Dimitri (Sheffield) & R Crowley (Birmingham)
    Body composition and bone
    S10.1
    Symposium 10: Fat and bone
    Fat and its influence on bone
    S10.2
    Symposium 10: Fat and bone
    Obesity and fractures - what is the inter-relationship?
    S10.3
    Symposium 10: Fat and bone
    Energy Deficiency, Amenorrhea and the Skeleton:  Challenges and Therapies
    16:45 - 17:30 
    Meet the Expert 5
    Supported by Clinical Endocrinology
    3B
    Chair: P Trainer (Manchester)
    MTE5
    Meet the Expert 5
    Pituitary replacement therapy
    17:40 - 18:10 
    Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
    Supported by Clinical Endocrinology Trust
    1A
    Chair: J Connell (Dundee)
    PL3
    Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
    Adrenocortical tumours - from bench to bedside and back
    Würzburg, Germany
    19:30 -  
    Conference dinner and Awards Ceremony
    07:45 - 08:00 
    Breakfast
    08:00 - 08:45 
    Meet the Expert 5 (repeat)
    Supported by Clinical Endocrinology
    1A
    Chair: P Trainer (Manchester)
    MTE5
    Meet the Expert 5 (repeat)
    Pituitary replacement therapy (repeat)
    08:00 - 08:45 
    Meet the Expert 6
    Supported by Clinical Endocrinology
    3B
    Chair: C Brain (London)
    MTE6
    Meet the Expert 6
    Delayed puberty
    08:00 - 08:45 
    Meet the Expert 7
    Supported by Clinical Endocrinology and the Thyroid Eye Disease Charitable Trust
    1B
    Chair: J Gilbert (London)
    MTE7
    Meet the Expert 7
    Who should the endocrinologist ask the ophtalmologist to review?
    London, UK
    08:00 - 08:45 
    Society for Endocrinology Journal Awards
    1C
    Chair: D Ray (Manchester)
    JA 1
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Journal of Endocrinology: Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy
    Rochester, USA on behalf of the author group
    JA 2
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Journal of Molecular Endocrinology:Thyroid-specific inactivation of KIF3A alters TSH signaling pathway and leads to hypothyroidism
    Louvain-la-Neuve, Belgium on behalf of the author group
    JA 3
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Endocrine-Related Cancer: Highly prevalent TERT promoter mutations in aggressive thyroid cancers
    Baltimore, USA on behalf of the author group
    JA 4
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Clinical Endocrinology: What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS)
    JA 5
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Endocrine Connections: PKA regulatory subunit R2B is required for murine and human adipocyte differentiation
    Milan, Italy on behalf of the author group
    08:45 - 09:25 
    Society for Endocrinology AGM
    1A
    09:30 - 11:00 
    Education Workshop 2: Practical publishing advice
    3B
    Chair: D Ray (Manchester)
    EW2.1
    Education Workshop 2: Practical publishing advice
    Introduction
    EW2.2
    Education Workshop 2: Practical publishing advice
    Publishing ethics: Fabrication, Falsification and Plagiarism
    EW2.3
    Education Workshop 2: Practical publishing advice
    The peer review process
    Stockholm, Sweden
    EW2.4
    Education Workshop 2: Practical publishing advice
    Writing an attention grabbing abstract
    Essen, Germany
    EW2.5
    Education Workshop 2: Practical publishing advice
    Responding to reviewer comments
    EW2.6
    Education Workshop 2: Practical publishing advice
    The art of scientific writing
    London, UK
    EW2.7
    Education Workshop 2: Practical publishing advice
    Open Access
    Education Workshop 2: Practical publishing advice
    Questions and discussion
    09:30 - 11:00 
    Nurse Session 1 - Cushing's Syndrome
    1B
    Chairs: N Kieffer (Leicester) & J Andrew (Leeds)
    N1.1
    Nurse Session 1 - Cushing's Syndrome
    Investigating and Diagnosing Cushing’s Syndrome -not as straightforward as it seems?
    N1.2
    Nurse Session 1 - Cushing's Syndrome
    The role of the Endocrine Nurse in the Management of patients with Cushing’s syndrome
    Rotterdam, The Netherlands
    N1.3
    Nurse Session 1 - Cushing's Syndrome
    Why do ‘cured’ Cushing’s patients need long-term follow up?
    Barcelona, Spain
    N1.4
    Nurse Session 1 - Cushing's Syndrome
    Cushing’s patient experience
    09:30 - 11:00 
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    1C
    Chairs: S O'Rahilly (Cambridge) & S Virtue (Cambridge)
    Emerging biology of brown adipose tissue
    S11.1
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    Mechanisms of brown adipocyte determination
    Philadelphia, USA
    S11.2
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    The metabolic capacities of brown adipose tissue
    Stockholm, Sweden
    S11.3
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    How brown is human brown adipose tissue?
    Gothenburg, Sweden
    09:30 - 11:00 
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Supported by Clinical Endocrinology
    1A
    Chairs: H Gleeson (Leicester) & R El-Khairi (London)
    CMW3.1
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Adolescent health care in the UK in 2014
    CMW3.2
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Adrenal replacement in adolescents and young adults
    London, UK
    CMW3.3
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Optimising bone health in adolescents and young adults
    Birmingham, UK
    11:00 - 11:30 
    Tea & Coffee
    Exhibtion Hall
    11:30 - 12:00 
    Plenary Lecture 4: Society for Endocrinology European Medal Lecture
    1A
    Chair: G Williams (London)
    PL4
    Plenary Lecture 4: Society for Endocrinology European Medal Lecture
    Mechanisms of thyroid hormone resistance
    Rotterdam, Netherlands
    12:00 - 12:30 
    Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
    1A
    Chair: D Ray (Manchester)
    PL5
    Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
    Transcriptional Coordination of Circadian and Metabolic Physiology
    Philadelphia, USA
    12:30 - 13:45 
    Lunch & poster viewing
    Shortlisted posters attended
    Hall 2A
    12:45 - 13:45 
    Viropharma Industry Sponsored Satellite Symposia
    New insights in the management of Adrenal Insufficiency in the UK
    3AB
    Chair: S Pearce (Newcastle-Upon-Tyne)
    Viropharma Industry Sponsored Satellite Symposia
    Introduction: The unmet medical need in adrenal insufficiency and the importance of circadian rhythm
    Newcastle, UK
    Viropharma Industry Sponsored Satellite Symposia
    Adrenal Insufficiency today: the Salford project
    Viropharma Industry Sponsored Satellite Symposia
    Adrenal Insufficiency today: a report from the EU-AIR registry
    Leeds, UK
    Viropharma Industry Sponsored Satellite Symposia
    Patient cases and physician experience
    Naples, Italy
    Viropharma Industry Sponsored Satellite Symposia
    Closing remarks
    Newcastle, UK
    13:45 - 14:30 
    Meet the Expert 8
    1C
    Chair: C McCabe (Birmingham)
    MTE8
    Meet the Expert 8
    Growing organs in the lab
    13:45 - 15:15 
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    1B
    Chairs: L Shephard (Birmingham) & V Fazal-Sanderson (Oxford)
    N2.1
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    Background on the journey of endocrine nursing research
    N2.2
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    How to audit and evaluate your own practice
    N2.3
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    The role of the endocrine nurse in clinical trials
    N2.4
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    Independent nursing research
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    Questions and discussion
    13:45 - 15:15 
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    Supported by Endocrine Connections
    1A
    Chairs: R McCrimmon (Dundee) & B Challis (Cambridge)
    How the brain orchestrates glucose metabolism
    S12.1
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    How the brain senses blood glucose
    S12.2
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    Vagal control of energy metabolism
    S12.3
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    Does glucagon need the brain for its effects on blood glucose?
    13:45 - 15:15 
    Oral Communications 6: Clinical
    3B
    Chairs: R Semple (Cambridge) & A Puttanna (Walsall)
    OC6.1
    Oral Communications 6: Clinical
    Adverse outcome in glucocorticoid-induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
    OC6.2
    Oral Communications 6: Clinical
    Localising parathyroid adenomas. Which imaging modality is best? Pre-operative localisation studies in patients with primary hyperparathyroidism: a large audit in a London tertiary centre
    OC6.3
    Oral Communications 6: Clinical
    Sirolimus therapy for a patient with segmental overgrowth due to a mosaic activating mutation in phosphatidylinositol-3-kinase (PI3K)
    OC6.4
    Oral Communications 6: Clinical
    Reduced cognitive performance and altered white matter microstructure in young insulin-resistant women with polycystic ovary syndrome
    OC6.5
    Oral Communications 6: Clinical
    Effectiveness of metyrapone in 195 patients with Cushing’s syndrome
    OC6.6
    Oral Communications 6: Clinical
    11C-Methionine PET-CT co-registered with volume MRI: a novel adjunctive imaging modality to aid diagnosis and management in patients with pituitary adenomas
    14:30 - 15:15 
    Meet the Expert 9
    1C
    Chairs: H Turner (Oxford) & P Hadoke (Edinburgh)
    MTE9
    Meet the Expert 9
    Novel techniques to assess angiogenesis
    Paris, France
    15:15 - 15:45 
    Tea & Coffee
    Hall 2A
    15:45 - 16:15 
    Oral Communication and Poster Prize Ceremony
    1A
    Chairs: A Grossman (Oxford) & C McCabe (Birmingham)
    16:15 - 16:45 
    Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
    Supported by Clinical Endocrinology Trust
    1A
    Chair: G Williams (London)
    PL6
    Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
    Disorders of thyroid hormone action: insights from human genetics
    Cambridge, UK
    16:45 - 17:15 
    Plenary Lecture 7: Society for Endocrinology Medal Lecture
    1A
    Chair: D Ray (Manchester)
    PL7
    Plenary Lecture 7: Society for Endocrinology Medal Lecture
    The clock in the pituitary gland: timing annual cycles
    07:45 - 08:00 
    Breakfast
    08:00 - 08:45 
    Meet the Expert 1 (repeat)
    Supported by Clinical Endocrinology
    1B
    Chair: J Newell-Price (Sheffield)
    MTE1
    Meet the Expert 1 (repeat)
    Medical management of Cushing's syndrome (repeat)
    08:00 - 08:45 
    Meet the Expert 2 (repeat)
    Supported by Clinical Endocrinology
    1C
    Chair: N Gittoes (Birmingham)
    MTE2
    Meet the Expert 2 (repeat)
    Vitamin D replacement: how much, how often and for whom? (repeat)
    08:45 - 09:15 
    Plenary Lecture 8: Clinical Endocrinology Trust Lecture
    Supported by the Clinical Endocrinology Trust
    1A
    Chair: JS Bevan (Aberdeen)
    PL8
    Plenary Lecture 8: Clinical Endocrinology Trust Lecture
    Understanding glucocorticoid action, and the role of the glucocorticoid receptor
    09:15 - 09:45 
    Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
    1A
    Chair: C McCabe (Birmingham)
    PL9
    Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
    Male Fertility Regulation; achievements and frustrations
    Clayton, Australia
    09:45 - 10:15 
    Society for Endocrinology Emergency Endocrine Guidance
    1A
    Chair: J Franklyn (Birmingham)
    SFE1.1
    Society for Endocrinology Emergency Endocrine Guidance
    Acute Hypercalcaemia and Acute Hypocalcaemia
    UK
    SFE1.2
    Society for Endocrinology Emergency Endocrine Guidance
    Pituitary Apoplexy
    10:15 - 10:45 
    Tea & Coffee
    3AB
    10:45 - 11:30 
    Meet the Expert 6 (repeat)
    1B
    Chair: C Brain (London)
    MTE6
    Meet the Expert 6 (repeat)
    Delayed puberty (repeat)
    10:45 - 12:15 
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Supported by Endocrinology, Diabetes & Metabolism Case Reports and the Turner Syndrome Support Society
    1A
    Chairs: A Bates (Stourbridge) & J Thomas (Taunton)
    CMW4.1
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Cardiovascular risk in Turner's syndrome
    CMW4.2
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Valvular disease in prolactinomas- weighing up the evidence
    London, UK
    CMW4.3
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Cardiovascular risk in childhood cancer survivors
    10:45 - 12:45 
    Senior Endocrinologists' Session
    1C
    Chairs: B Cooke (Harpenden) & P Belchetz (Wetherby)
    SE1.4
    Senior Endocrinologists' Session
    The Foundling Hospital
    SE1.2
    Senior Endocrinologists' Session
    1776 Revolution in Liverpool. Matthew Dobson discovers Hyperglycaemia!
    SE1.3
    Senior Endocrinologists' Session
    Macroprolacin - To seek or ignore : a Trans-Atlantic Divide
    Dublin, Ireland
    SE1.1
    Senior Endocrinologists' Session
    How important is luck for major discoveries?
    SE1.5
    Senior Endocrinologists' Session
    Steroid Merchants of Edinburgh
    11:30 - 12:15 
    Meet the Expert 7 (repeat)
    Supported by Clinical Endocrinology and the Thyroid Eye Disease Charitable Trust
    1B
    Chair: J Gilbert (London)
    MTE7
    Meet the Expert 7 (repeat)
    Whom should the endocrinologist ask the ophtalmologist to review? (repeat)
    London, UK

    07:45 - 08:00 
    Breakfast
    07:45 -  
    Registration
    08:00 - 08:45 
    Meet the Expert 1
    Supported by Clinical Endocrinology
    3B
    Chair: J Newell-Price (Sheffield)
    MTE1
    Meet the Expert 1
    Medical management of Cushing's syndrome
    08:00 - 08:45 
    Meet the Expert 2
    Supported by Clinical Endocrinology
    1A
    Chair: N Gittoes (Birmingham)
    MTE2
    Meet the Expert 2
    Vitamin D replacement: how much, how often and for whom?
    08:00 - 08:45 
    Meet the Expert 3
    Supported by Clinical Endocrinology and the Klinefelter’s Syndrome Association UK
    1B
    Chair: H Jones (Barnsley)
    MTE3
    Meet the Expert 3
    Endocrine and non-endocrine management of Klinefelter's Syndrome
    Newcastle, UK
    08:00 - 08:45 
    Meet the Expert 4
    Supported by Clinical Endocrinology
    1C
    Chair: L Heisler (Cambridge)
    MTE4
    Meet the Expert 4
    Optogenetics illuminates neuroendocrinology
    09:00 - 10:30 
    Symposium 6: Thyroid cell biology comes to your clinic
    Supported by Journal of Molecular Endocrinology
    1C
    Chairs: C Spitzweg (Munich, Germany) & V Smith (Birmingham)
    Emerging models of clinical relevance to thyroid disease
    S6.1
    Symposium 6: Thyroid cell biology comes to your clinic
    Development of functional thyroid tissue from embryonic stem cells
    Brussels, Belgium
    S6.2
    Symposium 6: Thyroid cell biology comes to your clinic
    Factors involved in thyroid gland development and survival
    S6.3
    Symposium 6: Thyroid cell biology comes to your clinic
    PBF signalling in thyroid tumourigenesis
    Birmingham, UK
    09:00 - 10:30 
    Clinical Management Workshop 2: How do I do it?
    Supported by Endocrinology, Diabetes and Metabolism Case Reports CMW2.1 supported by Hypopara UK
    1A
    Chairs: J Ahlquist (Southend) & C Napier (Newcastle upon Tyne)
    CMW2.1
    Clinical Management Workshop 2: How do I do it?
    How do I localise parathyroid tumours?
    CMW2.2
    Clinical Management Workshop 2: How do I do it?
    How and when do I initiate treatment for central hypothyroidism?
    Milan, Italy
    CMW2.3
    Clinical Management Workshop 2: How do I do it?
    How do I manage adrenal replacement in pregnancy?
    CMW2.4
    Clinical Management Workshop 2: How do I do it?
    How do I investigate and manage sweating?
    CMW2.5
    Clinical Management Workshop 2: How do I do it?
    How and when do I treat the older male with a borderline testosterone?
    CMW2.6
    Clinical Management Workshop 2: How do I do it?
    How do I investigate and manage hyponatraemia?
    09:00 - 10:30 
    Oral Communications 3: Steroids
    3B
    Chairs: C Cummins (Toronto, Canada) & D Nanus (Birmingham)
    OC3.1
    Oral Communications 3: Steroids
    Lack of 11β-hydroxysteroid dehydrogenase type 1 ameliorates the adverse features of Cushing’s syndrome
    OC3.2
    Oral Communications 3: Steroids
    5α-Reductase is a regulator of glucocorticoid action and metabolic phenotype in human liver
    OC3.3
    Oral Communications 3: Steroids
    The 21-hydroxylase pseudogene may have a role in induction of tolerance to steroidogenic machinery
    OC3.4
    Oral Communications 3: Steroids
    Pre-receptor glucocorticoid metabolism across human ageing: the impact of gender and menopausal status
    OC3.5
    Oral Communications 3: Steroids
    Linking GWAS to gene function - CYP17A1 in hypertension
    OC3.6
    Oral Communications 3: Steroids
    Targeting of lysyl oxidase by steroids to reduce peritoneal fibrosis and scarring
    09:00 - 10:30 
    Symposium 7: Natriuretic peptides: so much more than salt and water
    1B
    Chairs: C McArdle (Bristol) & S Mirczuk (London)
    Novel functions for natriuretic peptides
    S7.1
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Guanylyl cyclases in cardiomyopathy
    Wuerzburg, Germany
    S7.2
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Natriuretic peptides in pituitary development and function
    S7.3
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Natriuretic peptides in cardiovascular disease
    10:30 - 11:00 
    Tea & Coffee
    Hall 2A
    11:00 - 11:30 
    Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
    1A
    Chair: A Grossman (Oxford)
    PL1
    Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
    Nuclear receptors, metabolism and the hunger games
    La Jolla, USA
    11:30 - 12:00 
    Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
    1A
    Chair: A Grossman (Oxford)
    PL2
    Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
    Coactivators: Master Genes for Physiology and Pathology
    Pittsburg, USA
    12:00 - 14:00 
    Lunch & poster viewing
    Odd-numbered posters attended 12:00 - 13:00; Even-numbered posters attended 13:00 - 14:00
    Hall 2A
    12:45 - 13:45 
    Ipsen Industry Sponsored Satellite Symposia
    Optimising outcomes for patients with acromegaly and NETs
    3AB
    Chair: A Grossman (Oxford)
    Ipsen Industry Sponsored Satellite Symposia
    High-dose lanreotide Autogel for treatment-naive patients with acromegaly: the results of the PRIMARYS trial
    Ipsen Industry Sponsored Satellite Symposia
    SAGIT – A disease staging tool to personalise patient management for acromegaly
    Hamburg, Germany
    Ipsen Industry Sponsored Satellite Symposia
    New data confirming the beneficial role of lanreotide Autogel in the management of patients with a NET
    Cardiff, United Kingdom
    14:00 - 15:30 
    Oral Communications 4: Thyroid and Bone
    1C
    Chairs: K Boelaert (Birmingham) & F Hannan (Liverpool)
    OC4.1
    Oral Communications 4: Thyroid and Bone
    Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 exert dominant-negative effects
    OC4.2
    Oral Communications 4: Thyroid and Bone
    PHOSPHO1: roles beyond skeletal mineralisation
    OC4.3
    Oral Communications 4: Thyroid and Bone
    TRα mutation causes a severe and thyroxine-resistant skeletal dysplasia
    OC4.4
    Oral Communications 4: Thyroid and Bone
    Thyroid hormones stimulate osteoclastogenesis via TRα-dependent actions in osteoblasts
    OC4.5
    Oral Communications 4: Thyroid and Bone
    A mutation in the 5’UTR of GNA11 causes familial hypocalciuric hypercalcemia type 2 (FHH2) due to reduced translational efficiency
    OC4.6
    Oral Communications 4: Thyroid and Bone
    An ENU-induced Tyr265Stop mutation in Polg2 is associated with renal calcification in RCALC2 mice
    Birmingham, UK
    14:00 - 15:30 
    Young Endocrinologists' Symposium: Establishing successful collaborations
    1B
    Chairs: A Lansdown (Cardiff) & G Begum (Manchester)
    Making the most of interdisciplinary collaborations and peer-to-peer networking
    YE1.1
    Young Endocrinologists' Symposium: Establishing successful collaborations
    What makes a successful collaboration between a basic scientist and a clinician?
    YE1.2
    Young Endocrinologists' Symposium: Establishing successful collaborations
    How do I talk to a bioinformatician/mathematician/engineer?
    YE1.3
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Industrial collaborations - where to start?
    YE1.4
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Biobanking – what is it, and how could they be beneficial to me?
    YE1.5
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Peer-to-peer collaborations: Importance of YE groups
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Panel discussion
    14:00 - 15:30 
    Symposium 8: Chronic disease and growth
    3B
    Chairs: F Ahmed (Glasgow) & L Dunford (Leicester)
    Chronic inflammation and growth hormone signalling
    S8.1
    Symposium 8: Chronic disease and growth